Archive
Every update, milestone, and publication from Seek Labs.
Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains July 22, 2025 SALT LAKE CITY, UT (Business Wire) — Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the inclusion of veterinary…
BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV) July 8, 2025 Read the Medium Article from our CEO, Jared Bauer, about the Urgent Need to Fight RSV Globally. Salt Lake City, UT (Business Wire) — Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and…
RSV Isn’t Just a Cold; It’s a Global Crisis We Keep Ignoring Why RSV is more dangerous than people think and what we’re doing to change that By Jared Bauer, CEO of Seek Labs | july 8, 2025 In January, my wife got sick. Really sick. RSV, influenza, and pneumonia, all at once. She’s a healthy,…
Seek Labs Maps Measles Virus with BioSeeker™, Opening the Door to First-Ever Programmable Antiviral Therapeutic Amid Global Outbreaks June 23, 2025 Read the Medium Article from our CEO, Jared Bauer, about how Mapping Measles and other viruses can bring us closer to global readiness against existing and emerging diseases. SALT LAKE CITY, UT (Business Wire)…
When Vaccines Aren’t Enough: Mapping Measles and Preparing for What’s Next Measles was supposed to be behind us. Instead, it’s back and it’s spreading. Jared Bauer, Ceo of Seek Labs | June 23, 2025 Consider a hypothetical but all-too-real scenario: In March 2025, Maria watched her son’s fever spike and rash worsen rapidly in their…
Seek Labs Unveils BioSeeker™ Bioseeker™ is the AI Discovery Engine Powering Seek Labs’ Mission to Outpace Disease with Faster, Smarter Global Health Solutions June 10, 2025 Read the Medium Article from our CEO, Jared Bauer, about how BioSeeker is redefining the fight against disease SALT LAKE CITY, UT, June 10, 2025 (Business Wire) – Seek…
We Don’t Wait for Change. We Build It. How Seek Labs’ BioSeeker Is Redefining the Fight Against Disease Jared Bauer, CEO of Seek LAbs | June 10, 2025 I’ve spent most of my life watching disease move faster than the systems built to stop it–faster than diagnostics, faster than therapeutics, faster than public policy. And…
Seek Labs Announces Leadership Transition as Keith Marmer, President, will Join Board of Directors May 23, 2025 Seek Labs today announced Keith Marmer’s transition from President to the company’s Board of Directors, effective June 30, 2025. As he moves into a new role as a Director, Marmer will continue to support Seek Labs’ long-term vision…
Seek Labs Showcases SeekIt™ at Aquaculture 2025 March 24, 2024 Seek Labs was proud to participate in Aquaculture 2025 in New Orleans, LA. Our VP of Research, Dr. Annie Roy, presented about our groundbreaking advancements in molecular diagnostics for aquaculture. As part of the Shrimp Health and Diseases Track, Dr. Roy introduced SeekIt™, the world’s…
Seek Labs Appoints Kim Wirthlin as Chief Strategy Officer March 19, 2025 SALT LAKE CITY, UT, March 19, 2024 (BusinessWire)- Seek Labs, a healthcare innovations company developing diagnostic and therapeutic solutions that have the potential to revolutionize the detection and treatment of diseases, is pleased to announce the appointment of Kim Wirthlin as Chief Strategy…
Seek Labs Recognized in the Global Seafood Advocate for Advancing Aquaculture Disease Detection March 11, 2025 Seek Labs is proud to be featured in the Global Seafood Advocate for our work in advancing pondside molecular diagnostics. Our Seekit™ WSSV Field Kit enables shrimp farmers to detect White spot syndrome virus (WSSV) on-site and in minutes,…
Craig Mosman, Chief Business Development Officer, to Step Down from Seek Labs and Move into Advisory Role January 10, 2025 Seek Labs announced today that Craig Mosman, Chief Business Development Officer, will be stepping down from his role, effective January 6, 2025. While stepping back from his current role, Mosman will continue to support the…
Stay connected
Stay connected to company milestones, scientific insights, and the work unfolding across BioSeeker, SAT, and Seek Diagnostics.